Pulse Biosciences News

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2024 Earnings Call Transcript

Yahoo FinanceMay 13 09:02 ET

Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript

Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript

Earnings Call TranscriptsMay 11 13:29 ET

Pulse Biosciences Insiders Added US$9.69m Of Stock To Their Holdings

Yahoo FinanceMay 11 08:46 ET

Is Pulse Biosciences (NASDAQ:PLSE) In A Good Position To Deliver On Growth Plans?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose mo

Simply Wall StMay 10 09:55 ET

Pulse Biosciences Announces First U.S. Procedure With the CellFX NsPFA Percutaneous Electrode System

HAYWARD, Calif.--(BUSINESS WIRE)--May 9, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, today

Pulse BiosciencesMay 9 00:00 ET

Q1 2024 Pulse Biosciences Inc Earnings Call

Yahoo FinanceMay 8 06:06 ET

Express News | Pulse Biosciences Inc: Fully Subscribed Rights Offering Would Fund Growth Plans of Co Into Q1 of 2026

ReutersMay 7 16:37 ET

Express News | Pulse Biosciences Inc: Decided to Change Rights Offering Record Date From May 16, 2024 to a Date in Mid-June

ReutersMay 7 16:37 ET

Express News | Pulse Biosciences: Approved Planned Rights Offering of up to $60 Mln Worth of Units, Will Be Available to All Holders of Record of Co's Common Stock

ReutersMay 7 16:37 ET

Pulse Biosciences | 10-Q: Quarterly report

Futu NewsMay 7 16:35 ET · Announcements

Press Release: Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results

Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results HAYWARD, Calif.--(BUSINESS WIRE)--May 07, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its

Dow JonesMay 7 16:06 ET

Express News | Pulse Biosciences Q1 EPS USD -0.18

ReutersMay 7 16:05 ET

Express News | Pulse Biosciences Q1 Net Income USD -10.137 Million

ReutersMay 7 16:05 ET

Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results

HAYWARD, Calif.--(BUSINESS WIRE)--May 7, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, today

Pulse BiosciencesMay 7 00:00 ET

Express News | Pulse Biosciences Announces Timing of Rights Offering for up to $60,000,000

ReutersMay 2 08:00 ET

Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000

HAYWARD, Calif.--(BUSINESS WIRE)--May 2, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablatio

Pulse BiosciencesMay 2 00:00 ET

Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024

HAYWARD, Calif.--(BUSINESS WIRE)--Apr. 24, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, tod

Pulse BiosciencesApr 24 00:00 ET

After the Recent Decline, Pulse Biosciences, Inc. (NASDAQ:PLSE) Top Key Executive Robert Duggan's Holdings Have Lost 13% of Their Value

Key Insights Insiders appear to have a vested interest in Pulse Biosciences' growth, as seen by their sizeable ownership 68% of the company is held by a single shareholder (Robert Duggan) Using da

Simply Wall StApr 5 07:19 ET

Pulse Biosciences to Sell Subscription Rights to Purchase up to 6M Units

Seeking AlphaApr 4 10:00 ET

Express News | Pulse Biosciences Shares Are Trading Lower After the Company Last Week Reported Q4 Financial Results. Also, the Company Announced Plans to Initiate a Rights Offering of up to $60 Million Worth of Units

Moomoo 24/7Apr 1 13:24 ET